A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
08/2007
08/09/2007	US20070184105 Comsposition for stablizing epigallocatechin gallate (egcg) in water phase and preparation method thereof
08/09/2007	US20070184066 Administering a mushroom extract of 100-2000 molecular weight obtained by aqueousextraction, dialysis, and subjecting the external fluid to chromatography;carcinogenic, -tumor, -metastasic agents; lung/large intestine cancers; induced byethyl carbamate, NNK or azoxymethane
08/09/2007	US20070184064 Chimeric peptide immunogens
08/09/2007	US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders
08/09/2007	US20070184022 Microsome vaccine
08/09/2007	US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same
08/09/2007	US20070181124 Method and apparatus for dispensing inhalator medicament
08/09/2007	DE102006005180A1 Indazol-heteroaryl-derivate Indazole-heteroaryl derivatives
08/09/2007	DE102006005179A1 Aminoindazolderivate Aminoindazolderivate
08/09/2007	CA2641899A1 Water-soluble cc-1065 analogs and their conjugates
08/09/2007	CA2640678A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
08/09/2007	CA2640598A1 Liposome preparation
08/09/2007	CA2640454A1 Compounds and methods for modulating protein trafficking
08/09/2007	CA2640030A1 Biodegradable non-ophthalmic implants and related methods
08/09/2007	CA2637836A1 Ang2 and vegf inhibitor combinations
08/09/2007	CA2637255A1 40-o-(2-hydroxyethyl)-rapamycin for treating tuberous sclerosis disorders
08/09/2007	CA2636981A1 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
08/09/2007	CA2635718A1 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders
08/09/2007	CA2635403A1 Compounds for the inhibition of integrins and use thereof
08/09/2007	CA2622679A1 Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone
08/08/2007	EP1816199A1 Mutants of thyroid stimulating hormone and methods based thereon
08/08/2007	EP1816194A1 Cancer-cell-specific proliferation inhibitors
08/08/2007	EP1816140A1 Anti-glypican 3 antibody having modified sugar chain
08/08/2007	EP1816125A1 Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
08/08/2007	EP1815873A1 Method and device for radiotherapy
08/08/2007	EP1815864A1 Method of suppressing metastasis of cancer cells and medicinal composition to be used therefor
08/08/2007	EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system
08/08/2007	EP1815859A2 Halimide, a cytotoxic marine natural product, and derivatives thereof
08/08/2007	EP1814982A1 Improved viral purification methods
08/08/2007	EP1814913A2 Antibody induced cell membrane wounding
08/08/2007	EP1814907A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
08/08/2007	EP1814866A2 Gonadotropin releasing hormone receptor antagonists
08/08/2007	EP1814864A1 Nitro indazole derivatives
08/08/2007	EP1814863A1 Indazole sulphonamide derivatives
08/08/2007	EP1814854A1 Cationic ceramides, and analogs thereof, and their use for preventing or treating cancer
08/08/2007	EP1814850A1 New histone deacetylases inhibitors
08/08/2007	EP1814841A2 Ceramides and apoptosis-signaling ligand
08/08/2007	EP1814595A1 Treatment of cancer with a combination of an agent that perturbs the egf signaling pathway and an oligonucleotide that reduces clusterin levels
08/08/2007	EP1814552A2 Compounds for treating protein-kinase mediated disorders
08/08/2007	EP1814540A2 Compositions useful to treat ocular neovascular diseases and macular degeneration
08/08/2007	EP1814536A1 Copper melphalan and copper tegafur used as anti-tumoral agents
08/08/2007	EP1814520A1 Pharmaceutical compositions comprising a camtothecin derivate
08/08/2007	EP1814392A2 Methods and compositions for treating chronic lymphocytic leukemia
08/08/2007	EP1814390A2 Methods of treating hematological malignancies with nucleoside analog drugs
08/08/2007	EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/08/2007	EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors
08/08/2007	EP1546127B1 Novel pyrimidineamide derivatives and the use thereof
08/08/2007	EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid
08/08/2007	EP1451219B1 Nuclear protein "shoca" - a component of the wnt signalling pathway
08/08/2007	EP1441717B1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
08/08/2007	EP1381387B1 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases
08/08/2007	EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage
08/08/2007	EP1324992B1 Cyclized benzamide neurokinin antagonists for use in therapy
08/08/2007	EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/08/2007	EP1108035B1 Treatment of cervical cancer
08/08/2007	EP1083914B1 Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
08/08/2007	EP0837129B1 Epimorphin antagonist and process for producing the same
08/08/2007	EP0706376B2 Anti-angiogenic compositions and methods of use
08/08/2007	CN1330771C Method of preparing peptide having trypsin inhibition activity by using complex enzyme enzymolysis oyster
08/08/2007	CN1330765C Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
08/08/2007	CN1330759C Nucleusase gene hTERT-5'R2 cDNA of inhibiting endgranulase activity and its recombined carrier and nucleusase
08/08/2007	CN1330754C Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/08/2007	CN1330748C Bacterial protection
08/08/2007	CN1330668C Antibodies to insulin-like growth factor I receptor
08/08/2007	CN1330665C Anti-cancer active protein of syngnathus
08/08/2007	CN1330650C Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
08/08/2007	CN1330641C Activator for peroxisome proliferator-responsive receptor delta
08/08/2007	CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/08/2007	CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/08/2007	CN1330635C Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method
08/08/2007	CN1330372C Stabilized Inteferon compsns
08/08/2007	CN1330369C Chinese Medicinal composition for anticancer and its preparation method
08/08/2007	CN1330358C Concurrent medicine for cancer in late stage or chemotherapy
08/08/2007	CN1330343C Life prolonging tumour inhibiting cancer treating Chinese medicine oral liquid and its preparation method
08/08/2007	CN1330338C Medicine for reinforcing primordial qi of late stage cancer patents
08/08/2007	CN1330308C Use of 4-pyridylmethylphthalazines for cancer treatment
08/08/2007	CN1330303C Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/08/2007	CN1330302C Novel substance originating in basidiomycete culture, process for producing same and use thereof
08/08/2007	CN1330299C Medicament composition for treating extracranial noumenal tumour
08/08/2007	CN101014625A Novel anti-IGF-IR antibodies and uses thereof
08/08/2007	CN101014623A Dr5抗体及其用途 Dr5 antibodies and their use
08/08/2007	CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase
08/08/2007	CN101014600A 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
08/08/2007	CN101014593A 1,2,3-triazole derivatives as receptor tyrosine kinase inhibitors
08/08/2007	CN101014592A Oxazole derivatives as HER tyrosine kinase inhibitors
08/08/2007	CN101014590A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
08/08/2007	CN101014386A Antagonist anti-cd40 monoclonal antibodies and methods for their use
08/08/2007	CN101014367A Adjuvant therapy with the use of anti-glypican 3 antibody
08/08/2007	CN101014366A Therapy of platinum-resistant cancer
08/08/2007	CN101014343A Tetracyclic lactam derivatives and uses thereof
08/08/2007	CN101014334A Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients
08/08/2007	CN101014330A Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
08/08/2007	CN101012276A Rana grahami antiblastic peptide, gene and variant thereof, and application in pharmacy
08/08/2007	CN101012268A Fasciation naematoloma ligarine extraction, preparing method thereof and use in preparing pharmaceutical for treating tumour
08/08/2007	CN101012262A Nucleic acid molecule RTN4BSR32 and application in preparation of anti-cancer drugs
08/08/2007	CN101012236A 3,7,10-trimethyl-r-aminopropyl silatranes derivative and preparing method thereof
08/08/2007	CN101012233A Thienopyrrolizine derivative, its preparing method and pharmaceutical composition containing the same
08/08/2007	CN101012232A Natural anti-cancer drugs monomer yuanhuacine, formulation of injection thereof and preparing method
08/08/2007	CN101012227A Novel 13-n-octylberberine derivative with antineoplastic action
08/08/2007	CN101012225A 3-Cyanoquinoline derivative, preparation method and medical use thereof

1 ... 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 ... 2211